{"id":"W2419582408","doi":"10.3899/jrheum.150844","title":"Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response","year":2016,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Antisynthetase syndrome; Medicine; Rituximab; Internal medicine; Polymyositis; Azathioprine; Gastroenterology; Cyclophosphamide; Interstitial lung disease; Dermatomyositis; Leflunomide; Myositis; Immunology; Methotrexate; Disease; Lung; Chemotherapy; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001526876,0.0001980392,0.0009480536,0.0001559079,0.0001200366,0.000009635018,0.0001120464,0.0001213139,0.00002186489],"category_scores_gemma":[0.0003085349,0.00008301574,0.0002003905,0.0001126547,0.0002711437,0.00008838798,0.00001654291,0.00008326965,0.000004276064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001554374,"about_ca_system_score_gemma":0.0001800429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001934912,"about_ca_topic_score_gemma":0.00006572508,"domain_scores_codex":[0.9977389,0.001054387,0.0006148858,0.0001209543,0.0001891602,0.0002817423],"domain_scores_gemma":[0.9967775,0.002217254,0.0005136253,0.0002790779,0.000139897,0.00007259599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04134876,0.005372848,0.9110519,0.0001329537,0.001399848,0.002723143,0.006903914,0.000001061509,0.01743299,0.0003916973,0.000438917,0.01280195],"study_design_scores_gemma":[0.02218031,0.00918761,0.8520629,0.0007394872,0.0005751292,0.1083298,0.0006661329,0.00005366806,0.003667813,0.0004200235,0.001953635,0.0001635503],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991896,0.000970975,0.00006590564,0.006318976,0.0001103307,0.0005349214,0.00007000079,0.000007294058,0.00002557691],"genre_scores_gemma":[0.9947525,0.005000034,0.00007488381,0.00009243642,0.000005724442,0.00001003384,0.000002858038,0.00001499232,0.00004650159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1056066,"threshold_uncertainty_score":0.3385284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01124701188518224,"score_gpt":0.2840269625740862,"score_spread":0.272779950688904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}